2013 Jan 9;14(1) 607
Anabolic Agents: Androst-4-ene-3,11,17-trione (11-ketoandrostenedione, adrenosterone) 17-methylepithiostanol (epistane) Ractopamine S-23 YK-11 Hormone and Metabolic Modulators: Apitegromab Diuretics and Masking Agents: Torasemide Manipulation of Blood and Blood Components: Voxelotor Stimulants: 1,3-dimethylamylamine (1,3 DMAA) 1,4-dimethylamylamine (1,4-DMAA) Solriamfetol Your concerns If you have any concerns about the prohibited status of your medications and their ingredients, we strongly advise that you speak to your National Anti-Doping Organisation (NADO) and check the medication (for example by using a drug database provided by your NADO find a list here: or GlobalDro ( The BIU cannot provide advice on specific supplements and whether they contain banned substances we can only advise on the risks so you might wish to use a risk minimisation programme recommended by your NADO
Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK (2008) Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression
Also, a few more names for methylhexanamine were added as examples to this section
Variations in the Vdr gene, specifically TaqI (rs731236) , FokI (rs2228570) , and ApaI (rs7975232) , are linked to an increased risk of LIDD 25,26
